Mixiii-BioMed 2019


View Program

David InterContinental, Tel Aviv, Israel, 14-16 May
Richmond Pharmacology to attend the Mixiii-BioMed in Tel Aviv, our delegation will be exhibiting as part of British Embassy Israel, Pavilion.

Testimonials

“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”

- Anonymous

“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”

- Anonymous

“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”

- Anonymous

Latest news

COVID-19 – External Monitoring Guidelines

01st Jul 2020

Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing

Read more ›

Update on COVID-19

29th May 2020

Richmond Pharmacology update on SARS-CoV-2 infection control and management of clinical trials

Read more ›

Statement on COVID-19

23rd Mar 2020

Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are

Read more ›

On Helix, Transforming new medicine discovery

14-16 May

Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON

View event ›